Lipoprotein (a)[Lp (a)] resembles low-density lipoprotein (LDL), with an LDL lipid core and
apolipoprotein B (apoB), but contains a unique apolipoprotein, apo (a). Elevated Lp (a) is an …

Saponarin, a flavonoid found in young green barley leaves, possesses potent antioxidant
activities, which are determined by its inhibition of malonaldehyde (MA) formation from …

Current literature indicates that there is a strong correlation between coronary artery disease
(CAD) and type 2 diabetes. The arteriosclerotic progression occurs earlier and in a greater …

Background Psoriasis is a systemic inflammatory disease associated with increased
cardiovascular (CV) risk and altered lipid metabolism. Tofacitinib is an oral Janus kinase …

Exposure to ionizing radiation results in injuries of the hematopoietic, gastrointestinal, and
respiratory systems, which are the leading causes responsible for morbidity and mortality …

Neuropathy and peripheral artery disease represent the main pathophysiological conditions
underlying diabetic foot. Several studies showed that Lipoprotein (a)—Lp (a)—and …

The prevalence of type 2 diabetes mellitus (T2DM) is increasing worldwide. T2DM is
associated with both microvascular (neuropathy, nephropathy and retinopathy) and …

Background Lipoprotein (a)[Lp (a)] is an independent risk factor for cardiovascular disease.
The interleukin-6 (IL-6) receptor antagonist tocilizumab has been shown to lower serum Lp …

Purpose of Review A considerable body of data from genetic and epidemiological studies
strongly support a causal relationship between high lipoprotein (a)[Lp (a)] levels, and the …

Introduction Tamoxifen is a selective estrogen receptor modulator widely used in the
treatment of breast cancer. Tamoxifen therapy is associated with lower circulating low …